Recent Progress in Gene Therapy for Cardiovascular Disease
スポンサーリンク
概要
- 論文の詳細を見る
Gene therapy is emerging as a potential strategy for the treatment of cardiovascular diseases, such as peripheral arterial disease, ischemic heart disease, restenosis after angioplasty, vascular bypass graft occlusion and transplant coronary vasculopathy, for which no known effective therapy exists. The first human trial in cardiovascular disease started in 1994 treating peripheral vascular disease with vascular endothelial growth factor (VEGF) and since then, many different potent angiogenic growth factors have been tested in clinical trials for the treatment of peripheral arterial disease. In addition, therapeutic angiogenesis using the VEGF gene has been used to treat ischemic heart disease since 1997. The results from these clinical trials have exceeded expectations; improvement in the clinical symptoms of peripheral arterial disease and ischemic heart disease has been reported. Another strategy for combating the disease processes, targeting the transcriptional process, has been tested in a human trial. IN particular, transfection of cis-element double-stranded (ds) oligodeoxynucleotides (ODN) (=decoy) is a powerful tool in a new class of anti-gene strategies. Transfection of ds-ODN corresponding to the cis sequence will attenuate the authentic cis-trans interaction, leading to removal of trans-factors from the endogenous cis-elements and subsequent modulation of gene expression. Genetically modified vein grafts transfected with a decoy against E2F, an essential transcription factor in cell cycle progression, appear to have long-term potency in human patients. There is great potential in gene therapy for cardiovascular disease.
- 社団法人日本循環器学会の論文
- 2002-11-20
著者
-
Morishita Ryuichi
Division Of Clinical Gene Therapy
-
Morishita Ryuichi
Division Of Gene Therapy Science Graduate School Of Medicine Osaka University
関連論文
- OE-071 A Genom-Wide Association Study of SNPs in the risk of Atherosclerosis Obliterans(Heart failure, clinical(01)(M),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- Variation in OSBPL10 is associated with dyslipidemia
- Association of Serum Oxidized Lipoprotein(a) Concentration with Coronary Artery Disease : Potential Role of Oxidized Lipoprotein(a) in the Vasucular Wall
- PJ-042 Pivotal Roles of CYLD (cylindromatosis) as a Deubiquitinating Enzyme in Vasculature(Atherosclerosis, basic(05)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- Lack of Association between the Hepatocyte Growth Factor Receptor, c-met, and the Anti-Apoptotic Action of Bag-1 in Endothelial Cells
- Recovery of Learning and Memory by Gene Therapy Using Hepatocyte Growth Factor Gene After Focal Cerebral Ishcemia in Rats(Gene Therapy/Genetic Engineering (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Gene Polymorphism of Myospryn (Cardiomyopathy-Associated 5) Is Associated with Left Ventricular Wall Thickness in Patients with Hypertension
- Inhibitory Effect of Chimera Decoy Oligodeoxynucleotides (ODN) against Ets and NFκ B on the Progression of Rabbit Experimental Aortic Aneurysms (AAA)
- Gene Therapy for Abdominal Aortic Aneurysm (AAA) using Decoy Strategy against ets binding site
- Effect of E2F decoy on inhibitation of neointima formation in pig coronary arteries after balloon injury and stent implantation
- Transcription factor, ets-1, is a novel angiogenic molecule : Implication to ciene therapy to treat peripheral arterial disease
- Novel molecular intervention to treat abdominal aortic aneurysms (AAA) using chimera decoy oligodeoxynucleotides (ODN) against ets and NFkB binding sites
- Therapeutic Angiogenesis Induced by Endotherial Nitric Oxide Synthase Gene through VEGF Expression in Rat Hindlimb Ischemia Model
- Polymorphism of myospryn is associated with left ventricular diastolic dysfunction
- Increase in DNA Synthesis of Cardiac Myocytes by Transfection ofP53 and Rb Antisense : Possibility of Cardiac Myocytes Regeneration
- OJ-024 New Mechanisms of an Angiotensin Receptor Blocker, Valsartan, on the Heart Failure through the Inhibition of Novel Anti-adhesion Molecule, Periostin(Heart failure, basic-2 (M) OJ4,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific
- Periostin as a Anti-adhesion Molecule Responsible for Ventricular Dilation(Heart Failure, Basic 3 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- OE-206 Development of Ribbon Type NF-κ B Decoy Oligodeoxynucleotides(Genetics/Genetically engineered models/Gene therapy-1(H/M), The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Nonviral HVJ (hemagglutinating virus of Japan) liposome-mediated retrograde gene transfer of human hepatocyte growth factor into rat nervous system promotes functional and histological recovery of the crushed nerve
- IS023 Antisense Proliferating-cell Nuclear Antigen Oligonucleotide Attenuates Cardiac Allograft Arteriopathy
- PJ-086 Regression of Experimental Rabbit Aortic Aneurysm by The Treatment with Chimera Decoy Oligodeoxynucleotides (ODN) against ets and NFkB(Gene Therapy 1 (IHD) : PJ15)(Poster Session (Japanese))
- PJ-654 Post-ischemic Administration of Fluvastatin Improves Cognitive Dysfunction in the Chronic Stage of Cerebral Infarction in Rat Model(Cerebrovascular circulation/Stroke-3 (H) PJ110,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meet
- PJ-652 Over-expression of HGF Improves Learning and Memory and Prevents Progressive Shrinkage of Thalamus in the Chronic Stage of Cerebral Infarction(Cerebrovascular circulation/Stroke-3 (H) PJ110,Poster Session (Japanese),The 70th Anniversary Annual Scie
- Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease
- Application of Decoy Oligodeoxynucleotides for Arthritis
- 3 Functional Analysis of Novel Antimicrobial Peptide, AG (Angiogenic Peptide)-30, with Angiongenic Property, toward Clinical Application(The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PE-275 A Novel Strategy of the Gene Therapy for PAD Using Small RNA Interference of Cold Shock Domain Protein A(PE046,Atherosclerosis (Basic, Clinical/Diagnosis) (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation
- PJ-250 Cold shock domain protein A, novel regulator of angiogenesis in heart.(Coronary circulation, basic/clinical(03)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- OE-185 Topical application of novel angiogenic peptide, AG-30, in wound healing model(Growth factor/Cytokine(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- OE-040 FHL-2 Expresses in Endothelial Cell and Suppresses VEGF-induced Angiogenesis Via Sphingosine Kinase-1(Arrhythmia, diagnosis/Pathophysiology/EPS(01)(A),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society
- OJ-195 Pivotal Roles of Deubiquitinating Enzymes UCHL1, HAUSP, and CYLD in Vasculature as an Anti-proliferative and Anti-inflammatory Effect(Atherosclerosis, basic-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Adipose Tissue-Derived Stromal Cells as a Novel Option for Regenerative Cell Therapy
- PJ-752 A Novel Model of Vasculogenesis From ES Cells for Vascular Research and Regenerative Medicine(Development and differentiation-4 (M) PJ129,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- Gene therapy for ischemic brain disease with special reference to vascular dementia
- PJ-709 Amyloid β 1-40 Disrupts Vascular Regeneration through the Inhibition of Endothelial Akt signaling(Regeneration (angionenesis/myocardial regeneration)-7 (M) PJ119,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japane
- PJ-477 A Therapeutic Strategy to Treat Brain Ischemia : Over-expression of Hepatocyte Growth Factor Gene Reduced Ischemic Injury in Rat Model(Cerebrovascular Circulation/Stroke 1 (H) : PJ80)(Poster Session (Japanese))
- PJ-188 Angiogenic and Anti-fibrotic Actions of Hepatocyte Growth Factor Improve Cardiac Dysfunction in Porcine Ischemic Cardiomyopathy(Genetics/Genetically engineered models/Gene therapy-3 (M) PJ32,Poster Session (Japanese),The 70th Anniversary Annual Sci
- PJ-098 Ubiquitin C-terminal Hydroxylase L1 (UCHL1), the Causative Genes of Inherited Parkinson's Disease, Has an Anti-inflammatory Action in Endothelial Cells(Molecular biology, vascular-3 (H) PJ17,Poster Session (Japanese),The 70th Anniversary Annual Sci
- Aging of Blood Vessels
- PJ-691 Inhibition of Development of Experimental Aortic Abdominal Aneurysm in Rat Model by Atorvastatin through Inhibition of Macrophage Migration(Peripheral circulation/Vascular disease-6, The 71st Annual Scientific Meeting of the Japanese Circulation So
- PE-543 Inhibiton of Experimental Aortic Abdominal Aneurysm by Angiotensin Receptor Blocker, Valsartan(Peripheral circulation/Vascular disease-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Two Years Follow-up of Clinical Trial of Human Gene Therapy for Peripheral Arterial Disease Using Hepatocyte Growth Factor Gene Transfer(Peripheral Circulation/Vascular Disease (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Clinical Trial of Human Gene Therapy Using Hepatocyte Growth Factor Gene Transfer(Translational Research in Cardiovascular Disease, The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- FRS-013 Long Term Evaluation of Clinical Trial of Human Gene Therapy for Peripheral Arterial Disease Using Hepatocyte Growth Factor Gene Transfer(Angiogenesis and Regeneration Medicine in Cardiovascular Medicine (M) : FRS3)(Featured Research Session (Engl
- Increase in Peripheral Blood Flow by Intravenous Administration of Prostaglandin E1 in Patients with Peripheral Arterial Disease, Accompanied by Up-Regulation of Hepatocyte Growth Factor
- Results of Safety from Human Clinical Gene Therapy Using HGF (TREAT-HGF)
- Long Term Evaluation of Results from the First Stage in the Clinical Trial of Gene Therapy for Peripheral Arterial Disease
- Clinical Results of TREAT-HGF (Japan Trial to Treat Peripheral Arterial Disease by Therapeutic Angiogenesis Using Hepatocyte Growth Factor Gene Transfer)
- Evaluation of utility of prostagrandin E1 in the patients with ASO : Protective effect on endothelial function through up-regulation of HGF
- No increase in human HGF concentration in the patients transfected with human HGF plasmid : preliminary clinical results from TREAT-HGF
- Preliminary clinical results from TREAT-HGF (Japan Trial to Treat Peripheral Arterial Disease by Therapeutic Angiogenesis Using HGF Gene Transfer)
- Preliminary clinical results from TREAT-HGF : Gene therapy for PAD
- 5 Clinical Trial of Human Gene Therapy for Peripheral Arterial Disease Using Hepatocyte Growth Factor Gene Transfer(Clinical Trials of Regeneration Therapy in Japan, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-391 Hypertension Accelerated Experimental Abdominal Aortic Aneurysm through Up-regulation of Transcription Factors, NFkB and Ets(Peripheral circulation-2 (H) OJ66,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japane
- OJ-338 Long Term Results and Sub-analysis from Clinical Trial of Human Gene Therapy for Peripheral Arterial Disease (PAD)(Genetics/Genetically engineered models/Gene therapy-1 (M) OJ57,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Me
- OJ-337 Regression of Abdominal Aortic Aneurysms by Chimeric Decoy Oligonucleotides against NF κ B and Ets Binding Sites in Rabbit Model(Genetics/Genetically engineered models/Gene therapy-1 (M) OJ57,Oral Presentation (Japanese),The 70th Anniversary Annual
- OJ-029 Suppression of Anastomotic Intimal Hyperplasia in Rabbit Hypercholesterolemic Model using Chimeric Decoy Oligodeoxynucleotides against NF κ B and E2F(Restenosis, basic/clinical-1 (IHD) OJ5,Oral Presentation (Japanese),The 70th Anniversary Annual Sc
- Regression of Experimental Rabbit Aortic Aneurysm by the Treatment with Chimeric Decoy Oligodeoxynucleotides (ODN) against Ets and NFkB(Gene Therapy 1 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Inhibitory Effect of NFκB Decoy Oligodeoxynucleotides (ODN) on the Neointimal Hyperplasia in Rabbit Vein Graft Model(Cardiovascular Surgery/CABG 2 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-090 Therapeutic angiogenesis by a transcription factor : Ets-1 for peripheral arterial disease(Gene Therapy 1 (IHD) : PJ15)(Poster Session (Japanese))
- OE-328 Increase in DNA Synthesis of Cardiomyocytes by Transfection of Antisense p53 and Rb Oligodeoxynucleotides : Possibility of Regeneration of Cardiomyocytes(Gene Therapy 2 (IHD) : OE41)(Oral Presentation (English))
- Acceleration of Neointimal Hyperplasia in Lp (a) Transgenic Mice : Contribution of Lp (a) in the Pathogenesis of Vascular Disease
- Novel High Efficiency Gene transfer Technique into neonatal cardiac myocyte : Second Generation of HVJ vector (HVJ-envelope)
- Gene therapy for preventing delayed neuronal death using hepatocyte growth factor
- Impairment of collateral formation in Lp(a) transgenic mice : Therapeutic angiogenesis induced by human hepatocyte growth factor (HGF) gene
- Acceleration of neointimal hyperplasia in Lp(a) transgenic mice : Contribution of Lp(a) in the pathogenesis of vascular disease
- PJ-341 Acceleration of wound healing by combination gene transfer of Hepatocyte Growth Factor and Prostacyclin Synthase with Shima Jet(Peripheral Circulation/Vascular Disease 3(H) : PJ57)(Poster Session (Japanese))
- PJ-751 Role of HIF-1 α on Vascular and Heart Development in Xenopus : HIF-1 α Regulated Cardiac Development Independent of Vascular or Blood Development(Development and differentiation-4 (M) PJ129,Poster Session (Japanese),The 70th Anniversary Annual Scie
- PE-383 HGF Gene Therapy Ameliorates Secondary Lymphedema through Lymphangiogenesis(Genetics/Genetically engineered models/Gene therapy-2 (M) PE64,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- Novel Therapeutic Approach Using siRNA to Reduce Plasama High Concentration of Lp(a)(Lipid Disorders 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Development of a Novel Ribbon-type Decoy Oligonucleotides to Treat Renal Damages Induced by Hypertension and Diabetes(Kidney/Renal Circulation 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-558 Improvement of Glomerulosclerosis by Aging in ACE-deficient Mouse(Kidney/Renal circulation-4 (H) PJ94,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- OE-211 Differentiation of ES cells into sprouting vessels on Matrigel without growth factors(Angiogenesis 1 (M) : OE26)(Oral Presentation (English))
- Vascular Specific Organogenesis from Embryonic Stem Cells on Three Dimensional Layer of Matrigel
- Inorganic polyphosphate differentiates human mesenchymal stem cells into osteoblastic cells
- Development of Novel High Throughput Functional Screening System Based on HVJ-E Vector : Screening of Anti-vascular Remodeling Factor in Hypertension(Hypertension, Basic 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-278 Important Role of Nuclear Factor-κ(NF κB) in Neointimal Formation in Porcine Balloon Injury Model(Infection/Inflammation/Immunity 3 (H) : PJ47)(Poster Session (Japanese))
- PJ-091 Improvement of Diabetic Neuropathy by HGF Gene Transfer(Gene Therapy 1 (IHD) : PJ15)(Poster Session (Japanese))
- PJ-089 Potential of Novel Ribbon-type E2F Decoy in vivo Neointimal Hyperplasia(Gene Therapy 1 (IHD) : PJ15)(Poster Session (Japanese))
- OJ-529 Ribozyme Oligonucleotides Against TGF-Beta Transferred by Ultrasound Inhibited the Progression of Diseases in Anti-Thy1 Model(Kidney/Renal Circulation 3 (H) : OJ65)(Oral Presentation (Japanese))
- OJ-377 Combination Therapy by ACEI and ARB on vascular remodeling in a porcine coronary artery injury model(Restenosis after Angioplasty, Basic/Clinical 3 (IHD) : OJ46)(Oral Presentation (Japanese))
- Gene Therapy to Treat Diabetic Neuropathy : Improvement of Diabetic Peripheral Neuropathy by HGF Gene and Prostacyclin Synthase Gene Transfer
- Co-Transfection of Human Hepatocyte Growth Factor and Prostacyclin Synthase Gene Enhanced Therapeutic Angiogenesis in Rat and Rabbit Ischemia Model
- 2 Stent-Based Local Delivery of Nuclear Factor-k B Decoy Attenuates In-Stent Restenosis in Hypercholesterolemic Rabbits(Young Investigator's Award Finalists Lecture (YIA),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- Development of Novel Therapeutic Angiogenesis Strategy Using Co-transfection of Human PGIS Gene with HGF as Preclinical Study
- A Novel Autologous Cell Therapy into Ischemic Limb Diseases by Adipose Tissue-derived Stromal Cells through Growth Factor Secretion(Vasoactive Compound/Growth Factor/Cytokine 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Exogenous expression of hepatocyte growth factor (HGF) in rat striatum by naked plasmid DNA
- Therapeutic Angiogenesis Induced by Hepatocyte Growth Factor : Potential Gene Therapy for Ischemic diseases
- IS026 Hypoxia Induced Endothelial Apoptosis Through the Activation of NFkB : In Vivo Evidence of Importance of NFkb in Endothelial Cell Regulation
- PJ-087 Enhanced Therapeutic Angiogenesis by Co-transfection of Prostacyclin Synthase Gene or Optimization of Intramuscular Injection of Naked Plasmid DMA(Gene Therapy 1 (IHD) : PJ15)(Poster Session (Japanese))
- Recent Progress in Gene Therapy for Cardiovascular Disease
- Therapeutic Angiogenesis Using Hepatocyte Growth Factor Gene Transfer
- The Role of Hepatocyte Growth Factor (HGF) in Vasculogenesis and Angiogenesis in Xenopus Development
- Hepatocyte growth factor specifies hemotopoitic mesoderm in Xenopus embryos
- Perspective in Progress of Cardiovascular Gene Therapy
- Therapeutic Angiogenesis Using HGF Gene to Treat Peripheral Arterial Disease (Results from TREAT-HGF)
- Therapeutic Angiogenesis Using HGF (Hepatocyte Growth Factor) Gene to Treat Ischemic Disease(Therapeutic Angiogenesis-Now and Future, The 69th Annual Scientific Meeting of the Japanese Circulation Society)